How Is Cyclosporine Monitored in Pyoderma Gangrenosum?
At a Glance
Cyclosporine for pyoderma gangrenosum needs regular blood pressure checks and lab tests, especially for kidney function and electrolytes. Report infection symptoms, severe muscle symptoms, confusion, seizures, or urination changes promptly; kidney and blood pressure problems may have no early symptoms.
New here?
Inciteful Med answers your health questions using peer-reviewed research, with sources you can check. Free to try.
In this answer
6 sections
Cyclosporine is a fast-acting systemic medication often used to bring severe pyoderma gangrenosum (PG) under control [1]. Managing painful PG ulcers can be exhausting, and adding frequent blood tests to your routine may feel like a burden. However, because cyclosporine suppresses the immune system and can affect organ function, careful monitoring is essential [2]. Regular blood pressure checks, lab tests, and medication reviews allow your care team to balance the benefits of healing your skin with the risks of side effects [3].
Before Starting Cyclosporine
Before your first dose, your doctor will likely check your baseline health to ensure cyclosporine is safe for you. This usually includes [3]:
- A comprehensive medication review (including over-the-counter drugs and supplements).
- Baseline blood pressure and kidney function tests.
- Checking your electrolytes (like potassium and magnesium), liver function, and cholesterol.
- A discussion about your vaccination status, as you should generally avoid “live” vaccines while taking immunosuppressants [2].
Essential Tests During Treatment
Your doctor will establish a schedule for lab tests and clinical checks. Monitoring is typically most frequent when you first start or change your dose, and then spaced out once your dose is stable.
- Blood Pressure Checks: Cyclosporine commonly increases blood pressure (hypertension) [3]. Your clinic will check this, but you may also need to log it at home. Use a validated cuff, sit quietly before measuring, and ask your doctor what specific blood pressure reading should prompt a call.
- Kidney Function Tests (Creatinine, eGFR, and Urinalysis): One of the most important risks with cyclosporine is kidney injury (nephrotoxicity) [3]. Regular blood tests measure creatinine (a waste product) and eGFR (estimated glomerular filtration rate, a measure of kidney function) to ensure your kidneys are filtering properly. Because kidney stress is often silent, these tests are crucial for deciding if your dose needs adjusting [4].
- Electrolyte Panels: Cyclosporine can alter your mineral balance, sometimes causing dangerously high potassium (hyperkalemia) or low magnesium [5].
- Complete Blood Count (CBC): This test checks your red cells, white cells, and platelets. While it can detect blood abnormalities like anemia, a normal CBC does not rule out an infection [6]. Infection risk is primarily monitored through your symptoms rather than just blood tests.
- Liver and Lipid Panels: Cyclosporine can affect your liver enzymes and cholesterol levels, requiring periodic checks [7].
- Cyclosporine Blood Levels: Cyclosporine has a “narrow therapeutic window,” meaning the difference between an effective dose and a toxic dose is small [8]. While not universally required for all short-term dermatology patients, your doctor may check your blood levels, especially if you take interacting medicines. This often requires a “trough” level—blood drawn at a highly specific time just before your next dose [9].
Possible Side Effects
The risk of side effects typically increases with higher doses or longer treatment [10]. It is important to report new symptoms to your doctor.
- Kidney and Blood Pressure Issues: As noted, kidney stress and high blood pressure are major concerns that often have no early symptoms [3] [11].
- Neurological Symptoms: Some patients experience tremors (shaking hands) or headaches [11]. In rare, severe cases, the drug can cause confusion or seizures [12].
- Cosmetic Changes: You may notice excess hair growth (hirsutism) or swollen gums (gingival hyperplasia) [10]. Meticulous brushing and flossing, along with regular dental visits, can help manage gum swelling.
- Infections: Immunosuppressants make you more vulnerable to infections [2]. Common illnesses may hit harder or last longer [13].
- Skin Cancer Risk: Long-term immune suppression can increase the risk of skin cancers. Daily sun protection and regular skin checks are recommended.
Food and Drug Interactions: What to Avoid
Cyclosporine interacts with many products, which can drastically alter how much of the drug stays in your body. Always check with a pharmacist before starting any new prescription, over-the-counter medicine, or supplement [14].
- Grapefruit and St. John’s wort: Grapefruit and grapefruit juice can dangerously increase cyclosporine levels. Conversely, the herbal mood supplement St. John’s wort can significantly lower them, potentially causing your PG to flare [15]. Avoid both.
- Cholesterol Medications (Statins): Cyclosporine increases the levels of many statins, raising the risk of severe muscle breakdown (rhabdomyolysis) [7] [16]. Do not stop your statin without advice, but contact your doctor immediately if you develop severe muscle pain or dark urine. Your statin dose may need to be adjusted or changed [6].
- Other Medications: Antifungal drugs, certain antibiotics (macrolides), blood pressure drugs (ACE inhibitors or ARBs), potassium supplements, and pain relievers like NSAIDs (ibuprofen, naproxen) can all interact with cyclosporine or add stress to your kidneys [17] [18].
Sick Days and Vaccinations
If you develop a fever, severe vomiting, or diarrhea, or if you need a vaccination, do not stop, start, or adjust your cyclosporine dose on your own.
- Dehydration: Severe vomiting or diarrhea can cause dehydration, which drastically increases the risk of sudden kidney injury when combined with cyclosporine [6]. Call your doctor for an individualized plan.
- Vaccines: “Live” vaccines are generally avoided while on immunosuppressive doses of cyclosporine. Non-live vaccines are usually safe but may be less effective; always discuss the timing with your care team [2].
When to Seek Medical Attention
Contact your care team the same day if you have:
- A persistent fever, new cough, painful urination, or a rapidly worsening PG ulcer with new redness, warmth, or foul-smelling drainage [2].
- Severe muscle pain or weakness, particularly if your urine looks dark [7].
Seek urgent emergency care if you experience:
Common questions in this guide
Which tests are usually checked while I take cyclosporine for pyoderma gangrenosum?
Why are kidney tests so important with cyclosporine?
Do I need a cyclosporine blood level test?
What side effects of cyclosporine should I report?
Which foods, medicines, or supplements can interact with cyclosporine?
When should I seek urgent help while taking cyclosporine?
What should I do if I have severe vomiting, diarrhea, or need a vaccine while taking cyclosporine?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.What exact blood pressure, creatinine, or potassium result should prompt me to call the clinic?
- 2.If I need my cyclosporine blood levels checked, exactly when should I have the blood drawn relative to my dose?
- 3.Are any of my current medications—especially my statin, blood pressure drugs, or supplements—interacting with cyclosporine?
- 4.What is our plan if I develop a severe stomach bug and cannot keep fluids down?
- 5.Which vaccines are safe for me to receive while taking this medication, and how should we time them?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
Related questions
References
References (18)
- 1
Pyoderma gangrenosum: pathogenetic mechanisms and their implications for treatment.
Moltrasio C, Romagnuolo M, Tavoletti G, et al.
Seminars in immunopathology 2025; (47(1)):38.
PMID: 41128863 - 2
Comparison of the two most commonly used treatments for pyoderma gangrenosum: results of the STOP GAP randomised controlled trial.
Ormerod AD, Thomas KS, Craig FE, et al.
BMJ (Clinical research ed.) 2015; (350()):h2958 doi:10.1136/bmj.h2958.
PMID: 26071094 - 3
Mycophenolate mofetil as adjunctive therapy to corticosteroids for the treatment of pyoderma gangrenosum: a case series and literature review.
Hrin ML, Bashyam AM, Huang WW, Feldman SR
International journal of dermatology 2021; (60(12)):e486-e492 doi:10.1111/ijd.15539.
PMID: 33739458 - 4
Risk factors for increased serum creatinine level in patients with psoriasis treated with cyclosporine in a real-world practice.
Hong JR, Lee YW, Choe YB, Ahn KJ
Dermatologic therapy 2019; (32(3)):e12875 doi:10.1111/dth.12875.
PMID: 30884082 - 5
The Management of Erythrodermic Psoriasis Complicated by Cyclosporine.
Rao S, Bernshteyn M, Sohal R, et al.
Case reports in dermatological medicine 2020; (2020()):5215478 doi:10.1155/2020/5215478.
PMID: 32963844 - 6
Double trouble: ciclosporin-simvastatin coinduced rhabdomyolysis.
Hafouda Y, Sharma A, Li V, Yesudian PD
BMJ case reports 2019; (12(11)) doi:10.1136/bcr-2018-225971.
PMID: 31772127 - 7
Investigating Transporter-Mediated Drug-Drug Interactions Using a Physiologically Based Pharmacokinetic Model of Rosuvastatin.
Wang Q, Zheng M, Leil T
CPT: pharmacometrics & systems pharmacology 2017; (6(4)):228-238 doi:10.1002/psp4.12168.
PMID: 28296193 - 8
Population pharmacokinetics of ciclosporin in allogeneic hematopoietic stem cell transplant recipients: C-reactive protein as a novel covariate for clearance.
Ling J, Yang XP, Dong LL, et al.
Journal of clinical pharmacy and therapeutics 2022; (47(4)):483-492 doi:10.1111/jcpt.13569.
PMID: 34779003 - 9
Therapeutic durg monitoring of cyclosporin using area under the curve in nephrotic syndrome.
Gaies E, Ben Sassi M, Charfi R, et al.
La Tunisie medicale 2019; (97(2)):360-364.
PMID: 31539095 - 10
Cyclosporine for Chronic Spontaneous Urticaria: A Meta-Analysis and Systematic Review.
Kulthanan K, Chaweekulrat P, Komoltri C, et al.
The journal of allergy and clinical immunology. In practice 2018; (6(2)):586-599 doi:10.1016/j.jaip.2017.07.017.
PMID: 28916431 - 11
Two Cases With Developing Neurologic Complications After Liver Transplant.
Bican Demir A, Erer Özbek S, Bora I, et al.
Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation 2016; (14(6)):685-687 doi:10.6002/ect.2014.0204.
PMID: 26643318 - 12
Unpredictable Cyclosporine Clearance in a Korean Patient With Aplastic Anemia With Adverse Effects: A Case Study.
Shihmanter R, Miller EB, Shvartsman E, Shmuely H
Therapeutic drug monitoring 2024; (46(5)):563-566 doi:10.1097/FTD.0000000000001244.
PMID: 39194229 - 13
Cutaneous Coinfection of Cytomegalovirus and Mycobacterium chelonae Accelerated by Immunosuppression.
Tsutsumi Y, Odani K, Kaneko Y, et al.
Case reports in pathology 2021; (2021()):8819560 doi:10.1155/2021/8819560.
PMID: 33564484 - 14
A clinically relevant pharmacokinetic interaction between cyclosporine and imatinib.
Atiq F, Broers AE, Andrews LM, et al.
European journal of clinical pharmacology 2016; (72(6)):719-23 doi:10.1007/s00228-016-2038-9.
PMID: 26965514 - 15
Clinical relevance of St. John's wort drug interactions revisited.
Nicolussi S, Drewe J, Butterweck V, Meyer Zu Schwabedissen HE
British journal of pharmacology 2020; (177(6)):1212-1226 doi:10.1111/bph.14936.
PMID: 31742659 - 16
Effect of Cyclosporin A and Impact of Dose Staggering on OATP1B1/1B3 Endogenous Substrates and Drug Probes for Assessing Clinical Drug Interactions.
Mochizuki T, Zamek-Gliszczynski MJ, Yoshida K, et al.
Clinical pharmacology and therapeutics 2022; (111(6)):1315-1323 doi:10.1002/cpt.2584.
PMID: 35292967 - 17
Drug-drug interactions between triazole antifungal agents used to treat invasive aspergillosis and immunosuppressants metabolized by cytochrome P450 3A4.
Groll AH, Townsend R, Desai A, et al.
Transplant infectious disease : an official journal of the Transplantation Society 2017; (19(5)) doi:10.1111/tid.12751.
PMID: 28722255 - 18
Pharmacokinetics and dose recommendations for cyclosporine and tacrolimus when coadministered with ABT-450, ombitasvir, and dasabuvir.
Badri P, Dutta S, Coakley E, et al.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2015; (15(5)):1313-22 doi:10.1111/ajt.13111.
PMID: 25708713
This page is for informational purposes only and does not constitute medical advice about cyclosporine or pyoderma gangrenosum. Your prescribing clinician should decide which tests, dose changes, and urgent steps are appropriate for you.
Get notified when new evidence is published on Pyoderma gangrenosum.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.